Clinical, and political, aspirations about the potential of hydroxychloroquine and chloroquine to become a widespread treatment for COVID-19 continue to decline with the US Food and Drug Administration recommending only limited use of the products.
FDA officials issued a safety announcement on 24 April stating that hydroxychloroquine and chloroquine, either alone or in combination...




